Mechanisms Of Complete Freund's Adjuvant Protection Against Diabetes in Bb Rats: Induction Of Non-Specific Suppressor Cells

References

• Bach J. F. Mechanisms of autoimmunity in insulin-dependent diabetes mcllitus. Clin Exp Immunol 1988; 72: 1–8
   PubMed Web of Science ®Google Scholar
• Castano L., Eisenbarth G. S. Type-1 diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 1990; 8: 647–679
   PubMed Web of Science ®Google Scholar
• Ikehara S., Kawamura M., Takao F., Inaba M., Yasumizu R., Than S., et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sri USA 1990; 87: 8341–8344
   PubMed Web of Science ®Google Scholar
• Leiter E. H., Serreze D. V. Autoimmune diabetes in the nonobese diabetic mouse: supression of immune defects by bone marrow transplantation and implications for therapy. Clin Immunol and Immunopaih 1991; 59: 323–334
   PubMedGoogle Scholar
• Like A. A., Guberski D. L., Butler L. Influence of environmental viral agents on frequency and tempo of diabetes mellitus in BB/Wor rats. Diabetes 1991; 40: 259–262
   PubMed Web of Science ®Google Scholar
• Wilberz S., Partke H. J., Dagnaes-Hanson J., Herberg L. Persistent MHV (mouse hepatitis virus) infection reduces the incidence of diabetes mellitus in non-obese diabetic mice. Diabetologia 1991; 34: 2–5
   PubMed Web of Science ®Google Scholar
• Toyota T., Satoh J., Oya K., Shintani S., Okano T. Streptococcal preparation (OK-432) inhibits development of type 1 diabetes in NOD mice. Diabetes 1986; 35: 496–499
   PubMed Web of Science ®Google Scholar
• Satoh J., Shintani S., Oya K., Tanaka S. I., Nobunaga T., Toyota T., et al. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Diabetes 1988; 37: 1188–1194
   PubMed Web of Science ®Google Scholar
• Kino K., Mizumoto K., Sone T., Yamaji T., Watanabe J., Yamashita A., et al. An immunomodulating protein, Ling Zhi (LZ-8) prevent insulitis in non-obese diabetic mice. Diabetologia 1990; 33: 713–718
   PubMed Web of Science ®Google Scholar
• Sadelain M. W. J., Qin H. Y., Lauzon J., Singh B. Prevention of Type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 1990; 39: 583–589
   PubMed Web of Science ®Google Scholar
• McLnerney M. F., Pek S. B., Thomas D. W. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice. Diabetes 1991; 40: 715–725
   PubMed Web of Science ®Google Scholar
• Sadelain M. W. J., Qin H. Y., Sumoski W., Parfrey N., Singh B., Rabinovitch A. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J Autoimmunity 1990; 3: 671–680
   PubMed Web of Science ®Google Scholar
• van den Brink M. R. M., Hunt L. E., Hiserodt J. C. In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats. J Exp Med 1990; 171: 197–210
   PubMed Web of Science ®Google Scholar
• Serreze D. V., Leiter E. H. Defective action of T suppressor cell function in non obese diabetic mice: potential relation to cytokine deficiencies. J. Immunol 1988; 140: 3801–3807
   PubMed Web of Science ®Google Scholar
• Boitard C. R., Yasunami R., Dardenne M., Bach J. F. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989; 169: 1669–1680
   PubMed Web of Science ®Google Scholar
• Mordes J. P., Desemone J., Rossini A. A. The BB rat. Diabetes/Metab Rev 1987; 3: 725–750
   PubMed Web of Science ®Google Scholar
• Greiner D. L., Mordes J. P., Handler E. S., Angelillo M., Nakamura N., Rossini A. A. Depletion of RT6.1+ T lymphocytes induces diabetes in resistant Bio Breeding/Worcester (BB/W) rats. J Exp Med 1987; 166: 461–475
   PubMed Web of Science ®Google Scholar
• Naji A., Silvers W. K., Bellgrau D., Anderson O., Plotkin S., Barker C. F. Prevention of diabetes in rats by bone marrow transplantation. Ann Surg 1981; 194: 328–338
   PubMed Web of Science ®Google Scholar
• Nakano K., Mordes J. P., Handler E. S., Greiner D. L., Rossini A. A. Role of host immune system in BB/Wor rat: predisposition to diabetes resides in bone marrow. Diabetes 1988; 37: 520–525
   PubMed Web of Science ®Google Scholar
• Rossini A. A., Faustman D., Woda B. A., Like A. A., Szymanski I., Mordes J. P. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. J Clin Invest 1984; 74: 39–46
   PubMed Web of Science ®Google Scholar
• Georgiou H. M., Bellgrau D. Thymus transplantation and disease prevention in the diabetes-prone Bio-Breeding rat. J Immunol 1989; 142: 3400–3405
   PubMed Web of Science ®Google Scholar
• Like A. A., Rossini A. A., Appel M. D., Guberski D. L., Williams R. M. Spontaneous diabetes mellitus: reversal and prevention in the BB/W rat with antiserum to rat lymphocytes. Science (Wash. DC) 1983; 206: 1421–1423
   Google Scholar
• Laupacis A., Stiller C. R., Gardell C., Keown P., Dupre J., Wallace C., et al. Cyclosporine prevents diabetes in BB Wistar rats. Lancet 1983; 1: 10–12
   PubMed Web of Science ®Google Scholar
• Like A. A., Biron C. A., Weringer E. J., Byman K., Sroczynski E., Guberski D. L. Prevention of diabetes in Bio Breeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 1986; 164: 145–149
   Web of Science ®Google Scholar
• Warren H. S., Vogel F. R., Chedid L. A. Current status of immunological adjuvants. Annu Rev Immunol 1986; 4: 369–388
   PubMed Web of Science ®Google Scholar
• Wilson C. A., Jacobs C., Baker P., Baskin D. G., Dower S., Lernmark A., et al. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J Immunol 1990; 144: 3784–3788
   PubMed Web of Science ®Google Scholar
• Zielasek J., Burkart V., Naylor P., Goldstein A., Kiesel U., Kolb H. Interleukin-2-dependent control of disease development in spontaneously diabetic BB rats. Immunology 1990; 69: 209–214
   PubMed Web of Science ®Google Scholar
• Serreze D. V., Hamaguchi K., Leiter E. H. Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmunity 1989; 2: 759–776
   PubMed Web of Science ®Google Scholar
• Satoh J., Seino H., Abo T., Tanaka S., Shintani S., Ohta S., et al. Recombinant human tumor necrosis factor a suppressor autoimmune diabetes in nonobese diabetic mice. J Clin Invest 1989; 84: 1345–1348
   PubMed Web of Science ®Google Scholar
• Jacob C. O., Sadakazu A., Michie S. A., McDevitt H. O., Acha-Orbea H. Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-cr and interleukin 1. Proc Natl Acad Sci USA 1990; 87: 968–972
   PubMed Web of Science ®Google Scholar